Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Can J Hosp Pharm ; 43(5): 221-5, xxxii, 1990 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10107924

RESUMEN

Due to an increase in cefoxitin use at The Mississauga Hospital, a Drug Utilization Review (DUR) was conducted as part of the DUR program. The study was designed to determine the cefoxitin prescribing pattern, assess the appropriateness of use, calculate the cost associated with inappropriate use, and estimate future potential cost savings. Two evaluators (pharmacist and infectious disease specialist), reviewed cefoxitin use retrospectively during a four-month period for 82 patients who received a total of 100 courses of therapy. The appropriateness of cefoxitin use was assessed according to the predefined criteria that were developed and accepted by the hospital pharmacy, infectious disease and medical staff. Cefoxitin was prescribed more frequently by the department of surgery (45%) of the courses studied, while the medical and obstetric and gynecology services were responsible for the remainder of courses (24% and 31% respectively). Overall, 42% of the courses were deemed inappropriate and 11% were questionable, based on the choice of agent (62%) and the duration of treatment and prophylaxis (33%). The observed inappropriate use represented 22% of the amount spent on the total cefoxitin treatment of the 82 study patients. If cefoxitin had been prescribed appropriately, an estimated $11,873 could potentially have been saved annually by the hospital. Based on these results, recommendations for improving the quality and quantity of cefoxitin use were developed. Follow-up concurrent DUR's with pharmacist interventions were initiated and found to be cost-effective.


Asunto(s)
Cefoxitina/administración & dosificación , Utilización de Medicamentos/estadística & datos numéricos , Servicio de Farmacia en Hospital/economía , Control de Costos/métodos , Recolección de Datos , Estudios de Evaluación como Asunto , Femenino , Hospitales con más de 500 Camas , Departamentos de Hospitales/estadística & datos numéricos , Humanos , Masculino , Ontario , Estudios Retrospectivos
2.
Can J Hosp Pharm ; 41(1): 11-6, 1988 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10286608

RESUMEN

In response to rising drug expenditures and pressure from hospital administration to contain drug costs, the department of pharmaceutical services at The Mississauga Hospital initiated a Drug Utilization Review (DUR) Program. The main purpose of this program was to contain the escalating drug budget through identifying and correcting areas of drug misuse, without compromising the quality of patient care. This article will describe the procedures involved in developing and implementing such a DUR program at our hospital and our experience to date. Both structured and informal strategies have been implemented, which have identified factual and potential cost savings. Overall, the DUR program has been well accepted by the medical staff and hospital administration.


Asunto(s)
Revisión Concurrente/métodos , Utilización de Medicamentos , Sistemas de Medicación en Hospital/normas , Revisión de Utilización de Recursos/métodos , Hospitales con más de 500 Camas , Ontario , Análisis de Sistemas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA